These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20128440)

  • 1. Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.
    Bugli F; Graffeo R; Pescatori M; Paroni Sterbini F; Torelli R; Masucci L; Manzara S; Fadda G
    New Microbiol; 2009 Oct; 32(4):341-9. PubMed ID: 20128440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
    Hong WW; Yen YH; Wu SC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.
    Burioni R; Plaisant P; Manzin A; Rosa D; Delli Carri V; Bugli F; Solforosi L; Abrignani S; Varaldo PE; Fadda G; Clementi M
    Hepatology; 1998 Sep; 28(3):810-4. PubMed ID: 9731577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Generation of human recombinant antibody Fab fragment and its IgG to adeno-associated virus type II from phage display library].
    Yao LS; Wang T; Liang MF; Yuan ZH; Ji Y; Wu XB; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):240-3. PubMed ID: 15340567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
    Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
    New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
    Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
    J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P; López JA; Elola C; Domingo CJ; Echevarria JM
    Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
    Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
    Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
    Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
    J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81.
    Allander T; Drakenberg K; Beyene A; Rosa D; Abrignani S; Houghton M; Widell A; Grillner L; Persson MAA
    J Gen Virol; 2000 Oct; 81(Pt 10):2451-2459. PubMed ID: 10993933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M; Mahler M; Koch J; Ji Y; Li D; Schmaljohn C; Bautz EK
    J Med Virol; 2003 Jan; 69(1):99-107. PubMed ID: 12436484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC).
    Nattermann J; Schneiders AM; Leifeld L; Langhans B; Schulz M; Inchauspé G; Matz B; Brackmann HH; Houghton M; Sauerbruch T; Spengler U
    J Hepatol; 2005 Apr; 42(4):499-504. PubMed ID: 15763336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
    Schofield DJ; Bartosch B; Shimizu YK; Allander T; Alter HJ; Emerson SU; Cosset FL; Purcell RH
    Hepatology; 2005 Nov; 42(5):1055-62. PubMed ID: 16250048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture.
    Bender E; Woof JM; Atkin JD; Barker MD; Bebbington CR; Burton DR
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):74-9. PubMed ID: 8518367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
    Wu SC; Lin YJ; Chou JW; Lin CW
    Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.
    Kramer RA; Marissen WE; Goudsmit J; Visser TJ; Clijsters-Van der Horst M; Bakker AQ; de Jong M; Jongeneelen M; Thijsse S; Backus HH; Rice AB; Weldon WC; Rupprecht CE; Dietzschold B; Bakker AB; de Kruif J
    Eur J Immunol; 2005 Jul; 35(7):2131-45. PubMed ID: 15971273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.